DrugPatentWatch Database Preview
Pharmadax Inc Company Profile
What is the competitive landscape for PHARMADAX INC, and what generic and branded alternatives to PHARMADAX INC drugs are available?
PHARMADAX INC has three approved drugs.
Summary for Pharmadax Inc
| US Patents: | 0 |
| Tradenames: | 3 |
| Ingredients: | 3 |
| NDAs: | 3 |
| Patent Litigation for Pharmadax Inc: | See patent lawsuits for Pharmadax Inc |
Drugs and US Patents for Pharmadax Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pharmadax Inc | QUETIAPINE FUMARATE | quetiapine fumarate | TABLET, EXTENDED RELEASE;ORAL | 206260-004 | May 9, 2017 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Pharmadax Inc | LEVETIRACETAM | levetiracetam | TABLET, EXTENDED RELEASE;ORAL | 201464-002 | May 25, 2012 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Pharmadax Inc | GLYBURIDE | glyburide | TABLET;ORAL | 203581-002 | Apr 14, 2016 | AB1 | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Pharmadax Inc | QUETIAPINE FUMARATE | quetiapine fumarate | TABLET, EXTENDED RELEASE;ORAL | 206260-001 | May 9, 2017 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Pharmadax Inc | LEVETIRACETAM | levetiracetam | TABLET, EXTENDED RELEASE;ORAL | 201464-001 | May 25, 2012 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Pharmadax Inc | QUETIAPINE FUMARATE | quetiapine fumarate | TABLET, EXTENDED RELEASE;ORAL | 206260-002 | May 9, 2017 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
